The present invention provides processes useful in the preparation of certain
3-adrenergic receptor agonists of the structural formula
##STR1##
the pharmaceutically acceptable salts thereof, and the hydrates of said pharmaceutically
acceptable salts, wherein HET is as described herein. The invention further provides
intermediates useful in the preparation of such agonists, and processes useful
in the production of such intermediates.
